Anti-ALS/ IGFALS/ ACLSD functional antibody

Anti-ALS/ IGFALS/ ACLSD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IGFALS/IGFALS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0279-Ab-1/ GM-Tg-hg-SE0279-Ab-2Anti-Human IGFALS monoclonal antibodyHuman
GM-Tg-rg-SE0279-Ab-1/ GM-Tg-rg-SE0279-Ab-2Anti-Rat IGFALS monoclonal antibodyRat
GM-Tg-mg-SE0279-Ab-1/ GM-Tg-mg-SE0279-Ab-2Anti-Mouse IGFALS monoclonal antibodyMouse
GM-Tg-cynog-SE0279-Ab-1/ GM-Tg-cynog-SE0279-Ab-2Anti-Cynomolgus/ Rhesus macaque IGFALS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0279-Ab-1/ GM-Tg-felg-SE0279-Ab-2Anti-Feline IGFALS monoclonal antibodyFeline
GM-Tg-cang-SE0279-Ab-1/ GM-Tg-cang-SE0279-Ab-2Anti-Canine IGFALS monoclonal antibodyCanine
GM-Tg-bovg-SE0279-Ab-1/ GM-Tg-bovg-SE0279-Ab-2Anti-Bovine IGFALS monoclonal antibodyBovine
GM-Tg-equg-SE0279-Ab-1/ GM-Tg-equg-SE0279-Ab-2Anti-Equine IGFALS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0279-Ab-1/ GM-Tg-hg-SE0279-Ab-2; GM-Tg-rg-SE0279-Ab-1/ GM-Tg-rg-SE0279-Ab-2;
GM-Tg-mg-SE0279-Ab-1/ GM-Tg-mg-SE0279-Ab-2; GM-Tg-cynog-SE0279-Ab-1/ GM-Tg-cynog-SE0279-Ab-2;
GM-Tg-felg-SE0279-Ab-1/ GM-Tg-felg-SE0279-Ab-2; GM-Tg-cang-SE0279-Ab-1/ GM-Tg-cang-SE0279-Ab-2;
GM-Tg-bovg-SE0279-Ab-1/ GM-Tg-bovg-SE0279-Ab-2; GM-Tg-equg-SE0279-Ab-1/ GM-Tg-equg-SE0279-Ab-2
Products NameAnti-IGFALS monoclonal antibody
Formatmab
Target NameIGFALS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IGFALS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0279-Ag-1Recombinant multi-species ALS/ IGFALS/ ACLSD protein
    CytokineGM-Tg-g-SE0279-Ag-1insulin-like growth factor binding protein, acid labile subunit (IGFALS) protein
    ORF Viral VectorpGMLP003307human IGFALS Lentivirus plasmid
    ORF Viral VectorvGMLP003307human IGFALS Lentivirus particle


    Target information

    Target IDGM-SE0279
    Target NameIGFALS
    Gene ID3483,16005,79438,722493,532494,111767589
    Gene Symbol and SynonymsACLSD,Albs,ALS,IGFALS
    Uniprot AccessionP35858,P35859
    Uniprot Entry NameALS_HUMAN,ALS_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000099769
    Target ClassificationN/A

    The target: IGFALS, gene name: IGFALS, also named as ACLSD, ALS. The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Defects in this gene are a cause of acid-labile subunit deficiency, which maifests itself in a delayed and slow puberty. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.